Morgan Stanley’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $125K | Sell |
315,571
-280,016
| -47% | -$111K | ﹤0.01% | 6049 |
|
|
2025
Q1 | $207K | Sell |
595,587
-508,841
| -46% | -$176K | ﹤0.01% | 5717 |
|
|
2024
Q4 | $653K | Sell |
1,104,428
-753,748
| -41% | -$446K | ﹤0.01% | 5310 |
|
|
2024
Q3 | $3.27M | Buy |
1,858,176
+3,408
| +0.2% | +$6K | ﹤0.01% | 4297 |
|
|
2024
Q2 | $2.54M | Sell |
1,854,768
-55,376
| -3% | -$75.9K | ﹤0.01% | 4399 |
|
|
2024
Q1 | $6.57M | Sell |
1,910,144
-1,916,086
| -50% | -$6.59M | ﹤0.01% | 3690 |
|
|
2023
Q4 | $9.41M | Buy |
3,826,230
+2,225,442
| +139% | +$5.47M | ﹤0.01% | 3964 |
|
|
2023
Q3 | $2.72M | Sell |
1,600,788
-91,101
| -5% | -$155K | ﹤0.01% | 4187 |
|
|
2023
Q2 | $5.08M | Sell |
1,691,889
-186,632
| -10% | -$560K | ﹤0.01% | 3769 |
|
|
2023
Q1 | $5.03M | Buy |
1,878,521
+57,157
| +3% | +$153K | ﹤0.01% | 3787 |
|
|
2022
Q4 | $15M | Buy |
1,821,364
+173,600
| +11% | +$1.43M | ﹤0.01% | 2633 |
|
|
2022
Q3 | $12.7M | Buy |
1,647,764
+568,986
| +53% | +$4.38M | ﹤0.01% | 2700 |
|
|
2022
Q2 | $3.08M | Sell |
1,078,778
-515,213
| -32% | -$1.47M | ﹤0.01% | 4179 |
|
|
2022
Q1 | $7.97M | Buy |
1,593,991
+933,752
| +141% | +$4.67M | ﹤0.01% | 3175 |
|
|
2021
Q4 | $13M | Buy |
660,239
+426,454
| +182% | +$8.37M | ﹤0.01% | 2635 |
|
|
2021
Q3 | $6.88M | Buy |
233,785
+219,831
| +1,575% | +$6.47M | ﹤0.01% | 3342 |
|
|
2021
Q2 | $591K | Buy |
+13,954
| New | +$591K | ﹤0.01% | 5418 |
|
|
2021
Q1 | – | Sell |
-200
| Closed | -$7K | – | 7485 |
|
|
2020
Q4 | $7K | Buy |
+200
| New | +$7K | ﹤0.01% | 6710 |
|